{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T15:29:36Z","timestamp":1777476576842,"version":"3.51.4"},"update-to":[{"DOI":"10.1016\/j.contraception.2025.110864","type":"withdrawal","label":"Withdrawal","source":"publisher","updated":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000}}],"reference-count":92,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","contraceptionjournal.org","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.contraception.2025.110864","type":"journal-article","created":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T07:21:41Z","timestamp":1741591301000},"page":"110864","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["WITHDRAWN: Society of Family Planning Clinical Recommendation: Telemedicine in family planning care part 2 - Abortion"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7491-5287","authenticated-orcid":false,"given":"Rajita","family":"Patil","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Divya","family":"Dethier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Montida","family":"Fleming","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Godfrey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia E.","family":"Kohn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2025.110864_bib1","unstructured":"Patil R., Dethier D., Fleming M., et al. Society of Family Planning Committee Statement: Telemedicine in family planning care part 1 \u2013 Background and overarching principles. Contraception n.d."},{"key":"10.1016\/j.contraception.2025.110864_bib2","unstructured":"Patil R., Dethier D., Fleming M., et al. Society of Family Planning Clinical Recommendation: Telemedicine in family planning care part 3 - Contraception. Contraception n.d."},{"key":"10.1016\/j.contraception.2025.110864_bib3","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1001\/jama.2021.0282","article-title":"Telehealth use among safety-net organizations in California during the COVID-19 pandemic","volume":"325","author":"Uscher-Pines","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.contraception.2025.110864_bib4","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/s41591-024-02834-w","article-title":"Effectiveness and safety of telehealth medication abortion in the USA","volume":"30","author":"Upadhyay","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.contraception.2025.110864_bib5","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2105\/AJPH.2023.307437","article-title":"Patient acceptability of telehealth medication abortion care in the United States, 2021\u20132022: A cohort study","volume":"114","author":"Koenig","year":"2024","journal-title":"Am J Public Health"},{"key":"10.1016\/j.contraception.2025.110864_bib6","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.contraception.2022.06.009","article-title":"Telemedicine for medical abortion service provision in Mexico: A safety, feasibility, and acceptability study","volume":"114","author":"Pe\u00f1a","year":"2022","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.110864_bib7","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/ajo.12800","article-title":"A direct-to-patient telemedicine abortion service in Australia: Retrospective analysis of the first 18 months","volume":"58","author":"Hyland","year":"2018","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.contraception.2025.110864_bib8","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/13625187.2023.2170710","article-title":"Telemedicine medical abortion service in Georgia: an evaluation of a strategy with reduced number of in-Clinic visits","volume":"28","author":"Tsereteli","year":"2023","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2025.110864_bib9","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S0140-6736(14)61054-0","article-title":"Clinical follow-up compared with self-assessment of outcome after medical abortion: a multicentre, non-inferiority, randomised, controlled trial","volume":"385","author":"Oppegaard","year":"2015","journal-title":"The Lancet"},{"key":"10.1016\/j.contraception.2025.110864_bib10","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.contraception.2014.11.004","article-title":"Acceptability and feasibility of phone follow-up with a semiquantitative urine pregnancy test after medical abortion in Moldova and Uzbekistan","volume":"91","author":"Platais","year":"2015","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.110864_bib11","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.contraception.2022.06.010","article-title":"Effectiveness and safety of a direct-to-patient telehealth service providing medication abortion targeted at rural and remote populations: Cross-sectional findings from Marie Stopes Australia","volume":"115","author":"Seymour","year":"2022","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.110864_bib12","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/AOG.0000000000000050","article-title":"Acceptability and feasibility of phone follow-up after early medical abortion in Vietnam: A randomized controlled trial","volume":"123","author":"Ngoc","year":"2014","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2025.110864_bib13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.contraception.2014.03.016","article-title":"RU OK? The acceptability and feasibility of remote technologies for follow-up after early medical abortion","volume":"90","author":"Bracken","year":"2014","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.110864_bib14","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1111\/1471-0528.16668","article-title":"Effectiveness, safety and acceptability of no-test medical abortion (termination of pregnancy) provided via telemedicine: a national cohort study","volume":"128","author":"Aiken","year":"2021","journal-title":"BJOG Int J Obstet Gynaecol"},{"key":"10.1016\/j.contraception.2025.110864_bib15","article-title":"Self reported outcomes and adverse events after medical abortion through online telemedicine: Population based study in the Republic of Ireland and Northern Ireland","volume":"357","author":"Aiken","year":"2017","journal-title":"BMJ Online"},{"key":"10.1016\/j.contraception.2025.110864_bib16","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/S0140-6736(22)01474-X","article-title":"A telemedicine model for abortion in South Africa: a randomised, controlled, non-inferiority trial","volume":"400","author":"Endler","year":"2022","journal-title":"The Lancet"},{"key":"10.1016\/j.contraception.2025.110864_bib17","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.contraception.2013.11.005","article-title":"Provision of medical abortion using telemedicine in Brazil","volume":"89","author":"Gomperts","year":"2014","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.110864_bib18","first-page":"299","article-title":"The effectiveness of home medical abortions provided through telemedicine","volume":"131","author":"Gomperts","year":"2015","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.contraception.2025.110864_bib19","doi-asserted-by":"crossref","DOI":"10.1136\/bmjsrh-2022-201722","article-title":"A prospective, comparative study of clinical outcomes following clinic-based versus self-use of medical abortion","author":"Kapp","year":"2023","journal-title":"BMJ Sex Reprod Health"},{"key":"10.1016\/j.contraception.2025.110864_bib20","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1080\/13625187.2017.1397112","article-title":"Experiences of women living in Hungary seeking a medical abortion online","volume":"22","author":"Les","year":"2017","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2025.110864_bib21","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1136\/bmjsrh-2020-200976","article-title":"Telemedicine medical abortion at home under 12 weeks\u2019 gestation: A prospective observational cohort study during the COVID-19 pandemic","volume":"47","author":"Reynolds-Wright","year":"2021","journal-title":"BMJ Sex Reprod Health"},{"key":"10.1016\/j.contraception.2025.110864_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.conx.2020.100023","article-title":"Comparing telemedicine to in-clinic medication abortions induced with mifepristone and misoprostol","volume":"2","author":"Wiebe","year":"2020","journal-title":"Contracept X"},{"key":"10.1016\/j.contraception.2025.110864_bib23","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/1471-0528.15553","article-title":"Safety and acceptability of medical abortion through telemedicine after 9 weeks of gestation: a population-based cohort study","volume":"126","author":"Endler","year":"2019","journal-title":"BJOG Int J Obstet Gynaecol"},{"key":"10.1016\/j.contraception.2025.110864_bib24","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.contraception.2017.11.005","article-title":"Simplified medical abortion screening: a demonstration project","volume":"97","author":"Raymond","year":"2018","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.110864_bib25","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/1471-0528.15684","article-title":"Telemedicine for medical abortion: a systematic review","volume":"126","author":"Endler","year":"2019","journal-title":"BJOG Int J Obstet Gynaecol"},{"key":"10.1016\/j.contraception.2025.110864_bib26","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.ajog.2019.11.1244","article-title":"Follow-up strategies to confirm the success of medical abortion of pregnancies up to 10 weeks\u2019 gestation: a systematic review with meta-analyses","volume":"222","author":"Schmidt-Hansen","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2025.110864_bib27","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1001\/jamainternmed.2022.0217","article-title":"Outcomes and Safety of History-Based Screening for Medication Abortion: A Retrospective Multicenter Cohort Study","volume":"182","author":"Upadhyay","year":"2022","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.contraception.2025.110864_bib28","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.22320","article-title":"Safety and Efficacy of Telehealth Medication Abortions in the US During the COVID-19 Pandemic","volume":"4","author":"Upadhyay","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.contraception.2025.110864_bib29","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.contraception.2019.05.013","article-title":"TelAbortion: evaluation of a direct to patient telemedicine abortion service in the United States","volume":"100","author":"Raymond","year":"2019","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.110864_bib30","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.contraception.2021.03.019","article-title":"Expansion of a direct-to-patient telemedicine abortion service in the United States and experience during the COVID-19 pandemic","volume":"104","author":"Chong","year":"2021","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.110864_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.contraception.2023.110055","article-title":"Implications of using home urine pregnancy tests versus facility-based tests for assessment of outcome following medication abortion provided via telemedicine","volume":"124","author":"Anger","year":"2023","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.110864_bib32","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.contraception.2016.04.007","article-title":"Comparing office and telephone follow-up after medical abortion","volume":"94","author":"Chen","year":"2016","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.110864_bib33","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.contraception.2021.03.025","article-title":"Provision of medication abortion in Hawai\u2019i during COVID-19: Practical experience with multiple care delivery models","volume":"104","author":"Kerestes","year":"2021","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.110864_bib34","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.contraception.2021.07.108","article-title":"Clinical and service delivery implications of omitting ultrasound before medication abortion provided via direct-to-patient telemedicine and mail","volume":"104","author":"Anger","year":"2021","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.110864_bib35","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/AOG.0000000000002212","article-title":"Safety of Medical Abortion Provided Through Telemedicine Compared With In Person","volume":"130","author":"Grossman","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2025.110864_bib36","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/AOG.0b013e318224d110","article-title":"Effectiveness and acceptability of medical abortion provided through telemedicine","volume":"118","author":"Grossman","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2025.110864_bib37","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1001\/jama.2024.10680","article-title":"Comparison of no-test telehealth and in-person medication abortion","volume":"332","author":"Ralph","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.contraception.2025.110864_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.contraception.2024.110469","article-title":"An assessment of clinical outcomes of medication abortion without pretreatment ultrasonography in Planned Parenthood, United States, 2020\u20132021","volume":"136","author":"Simons","year":"2024","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.110864_bib39","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.contraception.2016.04.013","article-title":"Medical abortion reporting of efficacy: the MARE guidelines","volume":"94","author":"Creinin","year":"2016","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.110864_bib40","first-page":"11","article-title":"Surgical abortion for gestations of less than 6 weeks","author":"Edwards","year":"1997","journal-title":"Curr Probl Obstet Gynecol Fertil"},{"key":"10.1016\/j.contraception.2025.110864_bib41","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3109\/00016349209021052","article-title":"Medical termination of early pregnancy with mifepristone (RU 486) followed by a prostaglandin analogue: Study in 16, 369 women","volume":"71","author":"Ulmann","year":"1992","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.contraception.2025.110864_bib42","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/S0002-9378(97)70410-1","article-title":"New technologies permit safe abortion at less than six weeks\u2019 gestation and provide timely detection of ectopic gestation","volume":"176","author":"Edwards","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2025.110864_bib43","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.contraception.2014.01.010","article-title":"Simplified follow-up after early medical abortion: 12-month experience of a telephone call and self-performed low-sensitivity urine pregnancy test","volume":"89","author":"Michie","year":"2014","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.110864_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.conx.2021.100057","article-title":"Medical abortion at 13 or more weeks gestation provided through telemedicine: A retrospective review of services","volume":"3","author":"Kapp","year":"2021","journal-title":"Contracept X"},{"key":"10.1016\/j.contraception.2025.110864_bib45","unstructured":"Nippita S., Cansino C., Goldberg A., et al. Society of Family Planning Clinical Recommendation: Management of undesired pregnancy of unknown location and abortion at less than 42 days of gestation n.d."},{"key":"10.1016\/j.contraception.2025.110864_bib46","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.contraception.2021.04.026","article-title":"Family medicine provision of online medication abortion in three US states during COVID-19","volume":"104","author":"Godfrey","year":"2021","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.110864_bib47","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/AOG.0000000000004756","article-title":"Mifepristone and Misoprostol for Undesired Pregnancy of Unknown Location","volume":"139","author":"Goldberg","year":"2022","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2025.110864_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.contraception.2023.109980","article-title":"Medication abortion and uterine aspiration for undesired pregnancy of unknown location: A retrospective cohort study","volume":"122","author":"Borchert","year":"2023","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.110864_bib49","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMoa2401646","article-title":"Randomized Trial of Very Early Medication Abortion","volume":"391","author":"Brandell","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2025.110864_bib50","article-title":"Comparison of medication abortion outcomes at less than and greater than 6 weeks gestation","volume":"0","author":"Dethier","year":"2024","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.110864_bib51","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1097\/AOG.0000000000004082","article-title":"American College of Obstetricians and Gynecologists\u2019 Committee on Practice Bulletins\u2014Gynecology, Society of Family Planning. Medication Abortion Up to 70 Days of Gestation: ACOG Practice Bulletin, Number 225","volume":"136","year":"2020","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2025.110864_bib52","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.contraception.2020.04.005","article-title":"Commentary: No-test medication abortion: A sample protocol for increasing access during a pandemic and beyond","volume":"101","author":"Raymond","year":"2020","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.110864_bib53","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1471-0528.2010.02753.x","article-title":"Alternatives to routine ultrasound for eligibility assessment prior to early termination of pregnancy with mifepristone-misoprostol","volume":"118","author":"Bracken","year":"2011","journal-title":"BJOG Int J Obstet Gynaecol"},{"key":"10.1016\/j.contraception.2025.110864_bib54","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.contraception.2015.04.008","article-title":"Early medical abortion without prior ultrasound","volume":"92","author":"Raymond","year":"2015","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.110864_bib55","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.contraception.2014.07.004","article-title":"The accuracy of using last menstrual period to determine gestational age for first trimester medication abortion: a systematic review","volume":"90","author":"Schonberg","year":"2014","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.110864_bib56","doi-asserted-by":"crossref","first-page":"710.e1","DOI":"10.1016\/j.ajog.2021.11.1373","article-title":"Accuracy of self-assessment of gestational duration among people seeking abortion","volume":"226","author":"Ralph","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2025.110864_bib57","unstructured":"Guidance for providers offering misoprostol alone for abortion amidst COVID-19. 2020."},{"key":"10.1016\/j.contraception.2025.110864_bib58","unstructured":"Telehealth Care for Medication Abortion Workflow 2022."},{"key":"10.1016\/j.contraception.2025.110864_bib59","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1136\/bmjsrh-2023-201875","article-title":"Reversal of medication abortion with progesterone: a systematic review","volume":"50","author":"Stifani","year":"2024","journal-title":"BMJ Sex Reprod Health"},{"key":"10.1016\/j.contraception.2025.110864_bib60","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/AOG.0000000000003620","article-title":"Mifepristone antagonization with progesterone to prevent medical abortion: A randomized controlled trial","volume":"135","author":"Creinin","year":"2020","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2025.110864_bib61","unstructured":"American College of Obstetricians and Gynecologists. Medication abortion reversal is not supported by science n.d. https:\/\/www.acog.org\/advocacy\/facts-are-important\/medication-abortion-reversal-is-not-supported-by-science (accessed February 27, 2025)."},{"issue":"5","key":"10.1016\/j.contraception.2025.110864_bib62","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.contraception.2020.01.016","article-title":"When patients change their minds after starting an abortion: Guidance from the National Abortion Federation\u2019s Clinical Policies Committee","volume":"101","author":"Mark","year":"2020","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.110864_bib63","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/j.fertnstert.2008.01.084","article-title":"Ibuprofen and paracetamol for pain relief during medical abortion: a double-blind randomized controlled study","volume":"91","author":"Livshits","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2025.110864_bib64","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-066650","article-title":"Improving experience of medical abortion at home in a changing therapeutic, technological and regulatory landscape: a realist review","volume":"12","author":"Baraitser","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.contraception.2025.110864_bib65","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.contraception.2021.04.027","article-title":"Client satisfaction and experience of telemedicine and home use of mifepristone and misoprostol for abortion up to 10 weeks\u2019 gestation at British Pregnancy Advisory Service: A cross-sectional evaluation","volume":"104","author":"Meurice","year":"2021","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.110864_bib66","first-page":"1139","article-title":"Patient Perspectives Regarding Clinician Communication During Telemedicine Compared With In-Clinic Abortion","volume":"141","author":"Godfrey","year":"2023","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2025.110864_bib67","doi-asserted-by":"crossref","DOI":"10.21037\/mhealth-22-12","article-title":"Patient and provider experiences using a site-to-site telehealth model for medication abortion","volume":"8","author":"Ruggiero","year":"2022","journal-title":"mHealth"},{"key":"10.1016\/j.contraception.2025.110864_bib68","doi-asserted-by":"crossref","first-page":"e117","DOI":"10.1016\/j.whi.2012.12.002","article-title":"Women\u2019s and Providers\u2019 Experiences with Medical Abortion Provided Through Telemedicine: A Qualitative Study","volume":"23","author":"Grindlay","year":"2013","journal-title":"Womens Health Issues"},{"key":"10.1016\/j.contraception.2025.110864_bib69","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1136\/bmjsrh-2020-200612","article-title":"At-home telemedicine for medical abortion in Australia: A qualitative study of patient experiences and recommendations","volume":"46","author":"Fix","year":"2020","journal-title":"BMJ Sex Reprod Health"},{"key":"10.1016\/j.contraception.2025.110864_bib70","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1136\/bmjsrh-2021-201263","article-title":"Adherence to treatment and prevalence of side effects when medical abortion is delivered via telemedicine: a prospective observational cohort study during COVID-19","volume":"48","author":"Reynolds-Wright","year":"2022","journal-title":"BMJ Sex Reprod Health"},{"key":"10.1016\/j.contraception.2025.110864_bib71","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.whi.2021.02.007","article-title":"Pre-Abortion Informed Consent Through Telemedicine vs. in Person: Differences in Patient Demographics and Visit Satisfaction","volume":"31","author":"Kaller","year":"2021","journal-title":"Womens Health Issues"},{"key":"10.1016\/j.contraception.2025.110864_bib72","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/bmjsrh-2017-101818","article-title":"Telephone or integrated contraception counselling before abortion: impact on method choice and receipt","volume":"44","author":"Lohr","year":"2018","journal-title":"BMJ Sex Reprod Health"},{"key":"10.1016\/j.contraception.2025.110864_bib73","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.contraception.2017.12.009","article-title":"An exploration of perceived contraceptive coercion at the time of abortion","volume":"97","author":"Brandi","year":"2018","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.110864_bib74","unstructured":"Practice Advisory: Updated Mifepristone REMS Requirements 2023."},{"key":"10.1016\/j.contraception.2025.110864_bib75","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.bpobgyn.2019.07.012","article-title":"Reconceptualizing safe abortion and abortion services in the age of abortion pills: A discussion paper","volume":"63","author":"Berer","year":"2020","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.contraception.2025.110864_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.contraception.2023.109962","article-title":"Mailing abortion pills does not delay care: A cohort study comparing mailed to in-person dispensing of abortion medications in the United States","volume":"121","author":"Koenig","year":"2023","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.110864_bib77","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.contraception.2021.09.008","article-title":"Mail-order pharmacy dispensing of mifepristone for medication abortion after in-person clinical assessment","volume":"107","author":"Grossman","year":"2022","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.110864_bib78","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.contraception.2004.04.005","article-title":"Ability of the clinician and patient to predict the outcome of mifepristone and misoprostol medical abortion","volume":"70","author":"Rossi","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.110864_bib79","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/AOG.0b013e3181c996f3","article-title":"Alternatives to a Routine Follow-Up Visit for Early Medical Abortion","volume":"115","author":"Clark","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2025.110864_bib80","series-title":"Abortion care guideline","author":"World Health Organization","year":"2022"},{"key":"10.1016\/j.contraception.2025.110864_bib81","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1089\/jwh.2023.0531","article-title":"Medication abortion follow-up rates in a rural population before and after introduction of a remote follow-up option","volume":"32","author":"Chong","year":"2023","journal-title":"J Womens Health"},{"key":"10.1016\/j.contraception.2025.110864_bib82","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/AOG.0000000000003357","article-title":"Medication Abortion Provided Through Telemedicine in Four U.S. States","volume":"134","author":"Kohn","year":"2019","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2025.110864_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.contraception.2023.109996","article-title":"An examination of loss to follow-up and potential bias in outcome ascertainment in a study of direct-to-patient telemedicine abortion in the United States","volume":"122","author":"Rosenberg","year":"2023","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.110864_bib84","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1370\/afm.2821","article-title":"Remote Delivery in Reproductive Health Care: Operation of Direct-to-Patient Telehealth Medication Abortion Services in Diverse Settings","volume":"20","author":"Fiastro","year":"2022","journal-title":"Ann Fam Med"},{"key":"10.1016\/j.contraception.2025.110864_bib85","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.contraception.2010.08.023","article-title":"Alternatives to ultrasound for follow-up after medication abortion: A systematic review","volume":"83","author":"Grossman","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.110864_bib86","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.contraception.2011.11.010","article-title":"Telephone follow-up and self-performed urine pregnancy testing after early medical abortion: A service evaluation","volume":"86","author":"Cameron","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.110864_bib87","first-page":"52","article-title":"Instruction-only versus demonstration of a low sensitivity pregnancy test for self-assessment of medical abortion in South Africa; a multicentre non-inferiority randomised controlled trial","volume":"21","author":"Constant","year":"2016","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2025.110864_bib88","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.contraception.2021.02.004","article-title":"False positive\u201d urine pregnancy test results after successful medication abortion","volume":"103","author":"Raymond","year":"2021","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.110864_bib89","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/ijgo.12679","article-title":"Use of an at-home multilevel pregnancy test and an automated call-in system to follow-up the outcome of medical abortion","volume":"144","author":"Anger","year":"2019","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.contraception.2025.110864_bib90","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.contraception.2017.12.004","article-title":"Self-assessment of medical abortion outcome using symptoms and home pregnancy testing","volume":"97","author":"Raymond","year":"2018","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.110864_bib91","doi-asserted-by":"crossref","first-page":"w20531","DOI":"10.4414\/smw.2021.20531","article-title":"Remote self-assessment follow-up for medical termination of pregnancy at Geneva University Hospitals: an insight into its acceptability, success rate and costs","volume":"151","author":"Vanetti","year":"2021","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.contraception.2025.110864_bib92","unstructured":"NAF Sample Guideline: Medication Abortion Telephone Follow-Up 2020."}],"updated-by":[{"DOI":"10.1016\/j.contraception.2025.110864","type":"withdrawal","label":"Withdrawal","source":"publisher","updated":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000}}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782425000551?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782425000551?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T21:05:14Z","timestamp":1742504714000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782425000551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":92,"alternative-id":["S0010782425000551"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2025.110864","relation":{"withdrawal":[{"id-type":"doi","id":"10.1016\/j.contraception.2025.110864","asserted-by":"object"}]},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"WITHDRAWN: Society of Family Planning Clinical Recommendation: Telemedicine in family planning care part 2 - Abortion","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2025.110864","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110864"}}